ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia
Identifieur interne : 001D55 ( Istex/Curation ); précédent : 001D54; suivant : 001D56ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia
Auteurs : Luke R. G. Pike [Royaume-Uni] ; Kanchan Phadwal [Royaume-Uni] ; Anna Katharina Simon [Royaume-Uni] ; Adrian L. Harris [Royaume-Uni]Source :
- Molecular Biology Reports [ 0301-4851 ] ; 2012-12-01.
English descriptors
- KwdEn :
Abstract
Abstract: Intratumoral hypoxia is associated with poor prognosis, regardless of the mode of therapy. Cancer cells survive this condition through activating several adaptive signaling pathways, including the integrated stress response (ISR) and autophagy. Activating transcription factor 4 (ATF4) is the major transcriptional mediator of the ISR, which we have shown to be involved in autophagy regulation to protect cells from severe hypoxia. Here we demonstrate that ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. We find that the BH3-only proteins HRK, PUMA, and NOXA are transcriptionally induced in severe hypoxia and that their expression is abrogated by RNA interference against ATF4. In particular, we show that the BH3-only protein harakiri (HRK) is transactivated by ATF4 in severe hypoxia through direct binding of ATF4 to the promoter region. Furthermore, we demonstrate through siRNA knockdown that HRK induces autophagy and promotes cancer cell survival in severe hypoxia.
Url:
DOI: 10.1007/s11033-012-1975-3
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001D55
Links to Exploration step
ISTEX:947E42CAE9D5469915A897E6D11BD2B0014EC44DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia</title><author><name sortKey="Pike, Luke R G" sort="Pike, Luke R G" uniqKey="Pike L" first="Luke R. G." last="Pike">Luke R. G. Pike</name><affiliation wicri:level="1"><mods:affiliation>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford</wicri:regionArea></affiliation><affiliation><mods:affiliation>E-mail: lrgpike@gmail.com</mods:affiliation><wicri:noCountry code="no comma">E-mail: lrgpike@gmail.com</wicri:noCountry></affiliation></author><author><name sortKey="Phadwal, Kanchan" sort="Phadwal, Kanchan" uniqKey="Phadwal K" first="Kanchan" last="Phadwal">Kanchan Phadwal</name><affiliation wicri:level="1"><mods:affiliation>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>BRC Translational Immunology BRC lab, NIHR, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BRC Translational Immunology BRC lab, NIHR, Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Simon, Anna Katharina" sort="Simon, Anna Katharina" uniqKey="Simon A" first="Anna Katharina" last="Simon">Anna Katharina Simon</name><affiliation wicri:level="1"><mods:affiliation>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>BRC Translational Immunology BRC lab, NIHR, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BRC Translational Immunology BRC lab, NIHR, Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Harris, Adrian L" sort="Harris, Adrian L" uniqKey="Harris A" first="Adrian L." last="Harris">Adrian L. Harris</name><affiliation wicri:level="1"><mods:affiliation>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: aharris.lab@imm.ox.ac.uk</mods:affiliation><country wicri:rule="url">Royaume-Uni</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:947E42CAE9D5469915A897E6D11BD2B0014EC44D</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1007/s11033-012-1975-3</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-SJ2V1HW0-L/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D55</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D55</idno><idno type="wicri:Area/Istex/Curation">001D55</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia</title><author><name sortKey="Pike, Luke R G" sort="Pike, Luke R G" uniqKey="Pike L" first="Luke R. G." last="Pike">Luke R. G. Pike</name><affiliation wicri:level="1"><mods:affiliation>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford</wicri:regionArea></affiliation><affiliation><mods:affiliation>E-mail: lrgpike@gmail.com</mods:affiliation></affiliation></author><author><name sortKey="Phadwal, Kanchan" sort="Phadwal, Kanchan" uniqKey="Phadwal K" first="Kanchan" last="Phadwal">Kanchan Phadwal</name><affiliation wicri:level="1"><mods:affiliation>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>BRC Translational Immunology BRC lab, NIHR, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BRC Translational Immunology BRC lab, NIHR, Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Simon, Anna Katharina" sort="Simon, Anna Katharina" uniqKey="Simon A" first="Anna Katharina" last="Simon">Anna Katharina Simon</name><affiliation wicri:level="1"><mods:affiliation>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Nuffield Department of Medicine, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>BRC Translational Immunology BRC lab, NIHR, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BRC Translational Immunology BRC lab, NIHR, Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Harris, Adrian L" sort="Harris, Adrian L" uniqKey="Harris A" first="Adrian L." last="Harris">Adrian L. Harris</name><affiliation wicri:level="1"><mods:affiliation>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Growth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, OX3 9DS, Oxford</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: aharris.lab@imm.ox.ac.uk</mods:affiliation><country wicri:rule="url">Royaume-Uni</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Molecular Biology Reports</title><title level="j" type="sub">An International Journal on Molecular and Cellular Biology</title><title level="j" type="abbrev">Mol Biol Rep</title><idno type="ISSN">0301-4851</idno><idno type="eISSN">1573-4978</idno><imprint><publisher>Springer Netherlands</publisher><pubPlace>Dordrecht</pubPlace><date type="published" when="2012-12-01">2012-12-01</date><biblScope unit="volume">39</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="10811">10811</biblScope><biblScope unit="page" to="10822">10822</biblScope></imprint><idno type="ISSN">0301-4851</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0301-4851</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ATF4</term><term>BH3-only protein</term><term>HRK</term><term>Harakiri</term><term>Hypoxia</term><term>Integrated stress response</term><term>Unfolded protein response</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Intratumoral hypoxia is associated with poor prognosis, regardless of the mode of therapy. Cancer cells survive this condition through activating several adaptive signaling pathways, including the integrated stress response (ISR) and autophagy. Activating transcription factor 4 (ATF4) is the major transcriptional mediator of the ISR, which we have shown to be involved in autophagy regulation to protect cells from severe hypoxia. Here we demonstrate that ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. We find that the BH3-only proteins HRK, PUMA, and NOXA are transcriptionally induced in severe hypoxia and that their expression is abrogated by RNA interference against ATF4. In particular, we show that the BH3-only protein harakiri (HRK) is transactivated by ATF4 in severe hypoxia through direct binding of ATF4 to the promoter region. Furthermore, we demonstrate through siRNA knockdown that HRK induces autophagy and promotes cancer cell survival in severe hypoxia.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D55 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001D55 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:947E42CAE9D5469915A897E6D11BD2B0014EC44D
|texte= ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia
}}
| This area was generated with Dilib version V0.6.33. |  |